Quality of life of patients with refractory chronic rhinosinusitis: Effects of filgrastim treatment

American Journal of Rhinology

Volumn 15, Issue 4, 2001, Pages 231-237

  Van Agthoven, Michel ^a   Fokkens, Wytske J ^a   Van De Merwe, Joop P ^a   Van Bolhuis, E Marijke ^b   Uyl De Groot, Carin A ^a   Busschbach, Jan U V ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALAISE; MALE; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RHINOSINUSITIS; TREATMENT OUTCOME;

EID: 0034833630     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.1177/194589240101500403     Document Type: Article

References (33)

1. Kennedy DW, Wright ED, and Goldberg AN. Objective and subjective outcomes in surgery for chronic sinusitis. Laryngoscope 110:29-31, 2000.
2. Lanza DC, and Kennedy DW. Current concepts in the surgical management of nasal polyposis. J Allergy Clin Immunol 90:543-545, 1992
3. Senior BA, Kennedy DW, Tanabodee J, et al. Long-term results of functional endoscopic sinus surgery. Laryngoscope 108:151-157, 1998.
4. Stammberger H. Surgical treatment of nasal polyps: past, present, and future. Allergy 54:7-11, 1999.
5. Buehring I, Friedrich B, Schaaf J, et al. Chronic sinusitis refractory to standard management in patients with humoral immunodeficiencies. Clin Exp Immunol 109:468-472, 1997.
6. Polmar SH. The role of the immunologist in sinus disease. J Allergy Clin Immunol 90:511-514, 1992.
7. Shapiro GG, Virant FS, Furukawa CT. et al. Immunologic defects in patients with refractory sinusitis. Pediatrics 87:151-157, 1991
8. Dale DC, and Hammond WP IV. Cyclic neutropenia: a clinical review. Blood Rev 2:178-185, 1988.
9. Dale DC, Liles WC, Summer WR, and Nelson S. Review: granulocyte colony-stimulating factor. Role and relationships in infectious diseases. J Infect Dis 172:1061-1075, 1995.
10. Hartung T, von Aulock S, and Wendel A. Role of granulocyte colony-stimulating factor in infection and inflammation. Med Microbiol Immunol (Berl) 187:61-69, 1998.
11. Root RK, and Dale DC. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients. J Infect Dis 179:S342-S352, 1999.
12. Maune S, Rudert H, Heissenberg MC, et al. Concepts for measuring quality of life in patients with chronic sinusitis. Laryngorhinootologie 78:475-480, 1999.
13. Gliklich RE, and Hilinski JM, Longitudinal sensitivity of generic and specific health measures in chronic sinusitis. Qual Life Res 4:27-32, 1995.
14. Gliklich RE, and Metson R. Techniques for outcomes research in chronic sinusitis. Laryngoscope 105:387-390, 1995.
15. Alsarraf R, Kriet JD, and Weymuller EA Jr, Quality-of-life outcomes after osteoplastic frontal sinus obliteration. Otolaryngol Head Neck Surg 121:435-140, 1999.
16. Anderson ER, Murphy MP, and Weymuller EA Jr. Clinimetric evaluation of the Sinonasal Outcome Test-16. Student Research Award 1998. Otolaryngol Head Neck Surg 121:702-707, 1999.
17. Gliklich RE, and Metson R. Effect of sinus surgery on quality of life. Otolaryngol Head Neck Surg 117:12-17, 1997.
18. Metson R, and Gliklich RE. Clinical outcome of endoscopic surgery for frontal sinusitis. Arch Otolaryngol Head Neck Surg 124:1090-1096, 1998.
19. Ware JE, Kosinski M, and Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual, Boston, MA: The Health Institute, New England Medical Center, 1994.
20. Drummond MF, O'Brien BJ, Stoddart GL, and Torrance GW. Cost-utility analysis. In Methods for the Economical Evaluation of Health Care Programmes. Aberdeen, UK: Oxford University Press, 139-204, 1997.
21. Dolan P. Modeling valuations for the EuroQol health states. Med Care 35:1095-1108, 1997.
22. Hadom DC. The role of public values in setting health care priorities. Soc Sci Med 32:773-781, 1991.
23. Gold MR, Siegel JE, Russell LB, and Weinstein MC. Cost-effectiveness analysis as a Guide to Resource Allocation in Health: Roles and Limitations. In Cost-effectiveness in Health and Medicine. Russell LB, Siegel JE, Daniels N, Gold MR, Luce BR, Mandelblatt JS (Eds). Aberdeen, UK: Oxford University Press, 3-24, 1996.
24. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1:277-299, 1975.
25. Melzack R. The short-form McGill Pain Questionnaire. Pain 30:191-197, 1987.
26. Kloot WA, Oostendorp RAB, Meij J vd, and Heuvel J vd. The Dutch version of the McGill pain questionnaire: a reliable pain questionnaire [in Dutch]. Ned Tijdschr Geneesk 139:669-673, 1995.
27. Verkes RJ, Vanderiet K, Vertommen H. et al. The MPQ-DLV: The questionnaire. Lisse, The Netherlands: Swets & Zeitlinger. 1989.
28. Kloot A vd, and Vertommen H. The MPQ-DLV. A standard Dutch version of the McGill Pain Questionnaire. Backgrounds and manual [in Dutch]. Lisse, The Netherlands: Swets & Zeitlinger, 1989.
29. Ware JE, Snow KK, Kosinski M, and Gandek B. SF-36 Health Survey. In Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Center, 16, 1993.
30. EuroQol Group (Eds). EQ-5D User guide. A Measure of Health-Related Quality of Life Developed by the EuroQol Group, 6th issue, April 1999.
31. Kind P, Hardman G, Macran S. UK Population Norms for EQ-5D. University of York: Centre for Health Economics Discussion Paper 172:1999.
32. Aaronson NK, Muller M, Cohen PDA, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 51:1055-1068, 1998.
33. Metson RB, and Gliklich RE Clinical outcomes in patients with chronic sinusitis. Laryngoscope 110:24-28, 2000.